This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Mcgill University, Universitéde Montreal, Val-Chum, S.e.c.. Active years: 1998-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1998-2011
Title: Innovations by Diane Provencher
Introduction
Diane Provencher is a notable inventor based in St-Basile-le-Grand, Canada. She has made significant contributions to the field of medical research, particularly in ovarian cancer diagnostics and treatment. With two patents to her name, her work has the potential to impact cancer therapy significantly.
Latest Patents
Diane Provencher's latest patents include innovative methods for diagnosing ovarian cancer. One patent describes a method that involves providing a biological sample from a subject and detecting the expression levels of the markers FGF-2 and CA125. This method aims to enhance the accuracy of ovarian cancer diagnosis. Another patent focuses on primary cultures of normal and tumoral human ovarian epithelium. This invention relates to cell lines that are equivalent to the original clinical material, serving as a powerful model for studies that can lead to personalized cancer therapies.
Career Highlights
Throughout her career, Diane Provencher has worked with prestigious institutions, including the Université de Montréal and the Royal Institution for the Advancement of Learning/McGill University. Her research has been pivotal in advancing the understanding of ovarian cancer and developing effective treatment strategies.
Collaborations
Diane has collaborated with esteemed colleagues such as Anne-Marie Mes-Masson and Cécile LePage. These partnerships have contributed to her research's depth and breadth, enhancing the impact of her innovations.
Conclusion
Diane Provencher's work exemplifies the intersection of innovation and medical research. Her patents and collaborations reflect her commitment to improving cancer diagnostics and treatment. Through her contributions, she continues to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile